October 20, 2021
Partnership will focus on developing analytical solutions to better characterize bioprocesses towards improved quality, yields and efficiency News Summary: Waters and University of Delaware announce a multi-year collaboration to develop technology for analytical characterization of manufacturing processes for biologics and novel modalities. Waters’ staff and university researchers will co-locate at Immerse™ Delaware, an Innovation and [...]
October 20, 2021
BCP’s solutions to support implementation of end-to-end NGS workflows for clinical genomics applications and boost translational research at Bumrungrad BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced an expanded partnership with Bumrungrad International Hospital (Bangkok, Thailand), one of the largest private hospitals in Southeast Asia and a world leader in [...]
October 20, 2021
GUILDFORD, United Kingdom -- IDBS, the leading innovator in BioPharma Lifecycle Management (BPLM), announces its membership of BioPhorum. BioPhorum offers a space where biopharmaceutical manufacturers and suppliers can come together and discuss the many challenges in the industry, working collaboratively to address them. IDBS has joined the Information Technology Phorum (BPIT) which specifically addresses IT business goals. [...]
Parse Biosciences Unveils 1,000,000 Cell scRNA-seq Kit
October 20, 2021
The Evercode Whole Transcriptome Mega represents the most scalable and highest resolution single-cell platform to date Seattle, WA, Today at the annual American Society for Human Genetics meeting, Parse Biosciences, a company providing researchers with single-cell sequencing solutions, announced the launch of the most scalable single-cell RNA-seq solution on the market. The Evercode Whole Transcriptome Mega allows [...]
Twist Bioscience Launches Exome 2.0 for Genomics Research
October 20, 2021
- Best-in-Industry Exome Content and Performance - - Enables Lower Sequencing Costs through Best-in-Class Uniformity - SOUTH SAN FRANCISCO, Calif.--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of its Exome 2.0, featuring the most comprehensive coverage of [...]
October 20, 2021
Biotage AB (publ) (“Biotage”) has today entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited (“ATDBio”) based in Oxford and Southampton, UK, for a total purchase price of approx. 45 MGBP on a debt free and cash free basis (corresponding to approx. 534.4 MSEK[1]) financed through a combination [...]
LLR Partners Completes a Growth Investment in Genesee Scientific
October 19, 2021
SAN DIEGO & PHILADELPHIA--LLR Partners today announced an investment in Genesee Scientific, a manufacturer and distributor of products to global life science markets. The partnership will help enable Genesee’s continued growth through investment in its leading product portfolio, scaling of its national footprint and continued excellence in serving its laboratory customers. Genesee Scientific was founded in 1995 [...]
October 19, 2021
Verogen’s MiSeq FGx Sequencing System and ForenSeq DNA Signature Prep Kit will help resolve forensic investigations and complex relationship cases, and provide advanced phenotypic insights for the forensic community. SAN DIEGO–Verogen Inc., a dedicated developer of human identification products for sequencing and analysis of forensic genomic samples, is building on its partnership with Cellmark Forensic [...]
October 19, 2021
GUILFORD, Conn.--Quantum-Si Incorporated (NASDAQ: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life science tools company commercializing a unique protein sequencing platform, announced today that they have expanded their Platinum early access program to ten sites, with participation from leading academic centers and key industry partners. The early access program introduces the Platinum single molecule sequencing system [...]
INDIGO Biosciences Expands Portfolio for Preclinical Metabolic Disease Research
October 19, 2021
Fibroblast Growth Factor 21 Assay Targets NASH, NAFLD & Obesity Research STATE COLLEGE, Pa. -- INDIGO Biosciences, the recognized industry leader in nuclear receptor research, after the success of their Fibroblast Growth Factor Receptor 1 and 2 (FGFR1/2) assay, has expanded their robust preclinical testing portfolio to include a new Fibroblast Growth Factor 1c/Beta Klotho (FGFR/β-Klotho) assay. [...]

